DaehanPharmaceutical operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares DaehanPharmaceutical with three other
companies in this sector in KOREA (SOUTH) :
Kolon Life Science Incorporation
sales of 148.54 billion Korean Won [US$123.59 million]
of which 98%
Kyongbo Pharmaceutical Co Ltd
(191.71 billion Korean Won [US$159.50 million]
of which 37%
was General API), and
(176.50 billion Korean Won [US$146.85 million]
of which 95%
DaehanPharmaceutical reported sales of 336.82 billion Korean Won (US$280.23 million)
December of 2019.
increase of 112.2%
versus 2018, when the company's sales were 158.72 billion Korean Won .
Sales at DaehanPharmaceutical have increased during each of the previous five years
(and since 2014, sales have increased a total of 202%).